08 May 2023

GSK Stockmann contributed to the publication of the cross-border comparative report Securities Litigation by Lexology Getting the Deal Through

The new edition of the cross-border comparative report Securities Litigation has been published by Lexology Getting the Deal Through providing international expert analysis for corporate counsels, cross-border legal practitioners as well as company directors and officers.

The guide enables side-by-side comparison regarding the mechanisms and procedures surrounding securities litigation across the world’s markets, covering: types of securities claim; remedies and damages; plea requirements; early stage procedural mechanisms for defendants; collective proceedings; third-party litigation funding; litigation involving investment funds and structured finance; requirements for foreign residents and security holders; the handling of multiple securities claims in different jurisdictions; and available alternatives to litigation.

GSK Stockmann contributed to the publication of the cross-border comparative report: Andreas Heinzmann (Partner at GSK Stockmann in Luxembourg) and Dr. Manuel Fernandez (Local Partner at GSK Stockmann in Luxembourg) composed the chapter “Luxembourg“.

This chapter was originally published by Lexology Getting the Deal Through and is available for download as a PDF file. The whole guide can be access on the Lexology website.

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 28.02.2024

    GSK Update: GSK Stockmann contributed to the publication of the International Comparative Legal Guide to Mergers and Acquisitions

    Read more
  • 12.02.2024

    GSK Update: ESG regulation – an outlook on developments for the year 2024

    Read more
  • 12.02.2024

    GSK Update: Green securitisations under the new Europe-an Green Bonds Regulation

    Read more
Contact person

Andreas Heinzmann, LL.M. eur.

Partner

+352 271802-30

andreas.heinzmann@gsk-lux.com

Dr. Manuel Fernandez

Partner

+352 271802-31

manuel.fernandez@gsk-lux.com

© GSK Stockmann 2024